Testing effectiveness (Phase 2)Not Yet RecruitingNCT07453394
What this trial is testing
QLS5132 Combination Therapy in Advanced Solid Tumors
Who this might be right for
Gastric Cancer (GC)Non-small Cell Lung Cancer (NSCLC)Endometrial Cancer+2 more
Qilu Pharmaceutical Co., Ltd. 626